Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers

Published:2023-10 Issue: Volume:95 Page:129485
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Loy Cody A.,Muli Christine S.,Ali Eslam M.H.^ORCID,Xie Dan,Ahmed Mostafa H.,Beth Post Carol,Trader Darci J.^ORCID

Funder

National Institute of Allergy and Infectious Diseases Division of Intramural Research

National Institutes of Health

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. The proteasome: paradigm of a self-compartmentalizing protease;Baumeister;Cell,1998

2. Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of α′, β′-epoxyketone proteasome inhibitors;Groll;J Am Chem Soc,2000

3. Structure of 20S proteasome from yeast at 2.4Å resolution;Groll;Nature,1997

4. The proteasome under the microscope: the regulatory particle in focus;Lander;Curr Opin Struct Biol,2013

5. The regulatory particle of the Saccharomyces cerevisiae proteasome;Glickman;Mol Cell Biol,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation;2024-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP